Search results
1 company and 7 research reports found for "Cohort"
Company results
- Cohort
Cohort is a UK-based provider of services and products into the defence industry. The business opera...
Sector reports
No sector reports have been found.
Research results
Oxford BioMedica
Interim ProSavin update
Review | Pharmaceutical & Healthcare | 19/12/2011The positive Data Monitoring Committee (DMC) review of all four dose cohorts in the ProSavin Phase I/II Parkinson’s disease (PD) study confirmed...
Oxford BioMedica
December DMC and data
Update | Pharmaceutical & Healthcare | 17/11/2011Oxford BioMedica’s IMS highlighted clinical progress. The final ProSavin cohort in the Phase I/II has been dosed; in December data are expected ...
Oxford BioMedica
An important 12-18 mths
Outlook | Pharmaceutical & Healthcare | 09/09/2011Oxford BioMedica’s investment case is geared to securing a partner for ProSavin, and successful development of its ocular programmes, leading to...
Oxford BioMedica
Gimme five
Update | Pharmaceutical & Healthcare | 25/05/2011Further encouraging data from the 2x dose cohort Oxford BioMedica’s Phase I/II ProSavin Parkinson’s disease trial has been presented at the ASCGT ...
Oxford BioMedica
ProSavin to progress
Update | Pharmaceutical & Healthcare | 22/12/2010Three-month data from the third cohort (2x dose with new admin technique) in the ProSavin Phase I/II Parkinson’s disease trial showed comparable eff...
Cohort
Two out of three is bad
Update | Aerospace & Defence | 17/12/2010For the second year running, Cohort has produced a December profit warning. With management having nursed SCS slowly back to health and MASS continuin...
SuliXen Phase I data confirmed
Update | Pharmaceutical & Healthcare | 04/06/2008Lipoxen has reported positive results from the first cohort of its Phase I trial of SuliXen – its first clinical data for this product. This fol...
